ATOMIC AI Trademark

Trademark Overview


On Thursday, August 19, 2021, a trademark application was filed for ATOMIC AI with the United States Patent and Trademark Office. The USPTO has given the ATOMIC AI trademark a serial number of 90890805. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Tuesday, March 18, 2025. This trademark is owned by ATOMATAI, INC.. The ATOMIC AI trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations for the modification of RNA expression and alteration of RNA translation for the treatment of cancers and autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes

research and development in the fields of DNA and RNA; automated design and development of biomolecules for medical and scientific use, for use in the manufacture of biosensors, agriculture, synthetic biological research, laboratories and environmental safety and testing; drug design and development featuring machine-learning algorithms and lab automation tools
atomic ai

General Information


Serial Number90890805
Word MarkATOMIC AI
Filing DateThursday, August 19, 2021
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateTuesday, March 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparations for the modification of RNA expression and alteration of RNA translation for the treatment of cancers and autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes
NOT AVAILABLE"AI"
Goods and Servicesresearch and development in the fields of DNA and RNA; automated design and development of biomolecules for medical and scientific use, for use in the manufacture of biosensors, agriculture, synthetic biological research, laboratories and environmental safety and testing; drug design and development featuring machine-learning algorithms and lab automation tools

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameATOMIC AI, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080

Party NameATOMATAI, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events


Event DateEvent Description
Monday, August 23, 2021NEW APPLICATION ENTERED
Wednesday, October 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 23, 2022ASSIGNED TO EXAMINER
Tuesday, May 24, 2022NON-FINAL ACTION WRITTEN
Tuesday, May 24, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 9, 2023NON-FINAL ACTION WRITTEN
Monday, January 9, 2023NON-FINAL ACTION E-MAILED
Monday, January 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, January 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 31, 2023SUSPENSION LETTER WRITTEN
Tuesday, January 31, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, January 31, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 31, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, January 29, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, July 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 17, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, July 18, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 18, 2024SUSPENSION LETTER WRITTEN
Thursday, July 18, 2024LETTER OF SUSPENSION E-MAILED
Friday, January 31, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, January 31, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, February 12, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 18, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED